- Koexistencia inhibítorov SGLT2 a receptorových agonistov GLP1 v liečb…
Number of the records: 1  

Koexistencia inhibítorov SGLT2 a receptorových agonistov GLP1 v liečbe pacienta s diabetes mellitus 2. typu

  1. Koexistencia inhibítorov SGLT2 a receptorových agonistov GLP1 v liečbe pacienta s diabetes mellitus 2. typu = Coexistence of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of a patient with type 2 diabetes mellitus / Piotr Waszczuk. Diabetes a obezita Roč. 24, č. 47 (2024), s. 41-50
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.